In an era where medical science continually evolves, two pivotal areas of study are presenting groundbreaking findings likely to shape future therapeutic approaches. These research subjects delve into herpes simplex virus (HSV) mutations contributing to drug resistance and the intricate role of
In a groundbreaking development, QIMR Berghofer has made significant strides in combating severe viral infections in immunocompromised patients through their pioneering cell therapy. This innovative treatment has proven effective in 46 out of 71 patients, resulting in a notable 65% success rate.
Recent advancements in synthetic biology have opened new avenues for addressing antimicrobial resistance (AMR), a pressing global health threat. Synthetic biology encompasses the design and engineering of new or modified living systems to combat drug-resistant bacteria effectively. This field
The realm of bioprinting has witnessed a momentous development thanks to a team of innovative researchers at Penn State University. This scientific group has pioneered an advanced bioprinting technique that employs spheroids—clusters of cells—to fabricate complex tissue with enhanced precision and
Amgen's obesity drug candidate, MariTide (maridebart cafraglutide, formerly AMG 133), has brought forward promising results in a Phase II clinical trial, sparking hope for a new and effective treatment for obesity. With its innovative design and impressive efficacy, MariTide is positioned as a
Imagine the potential to unlock the secrets of how our bodies maintain health and prevent disease by understanding how stem cells perceive and adapt to their environment. This quest has driven researchers from The Hospital for Sick Children (SickKids) and Institut Curie to conduct an extensive
